PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) Stock Fundamental Analysis
Europe - EPA:ALPAT - FR0010785790 - Common Stock
8.42 EUR
-0.02 (-0.24%)
Taking everything into account, ALPAT scores 5 out of 10 in our fundamental rating. ALPAT was compared to 73 industry peers in the Biotechnology industry. While ALPAT is still in line with the averages on profitability rating, there are concerns on its financial health. ALPAT is evaluated to be cheap and growing strongly. This does not happen too often!
1. Profitability
1.1 Basic Checks
ALPAT had positive earnings in the past year.
In the past year ALPAT had a positive cash flow from operations.
In multiple years ALPAT reported negative net income over the last 5 years.
In multiple years ALPAT reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of ALPAT (5.84%) is better than 82.19% of its industry peers.
Looking at the Return On Equity, with a value of 9.95%, ALPAT belongs to the top of the industry, outperforming 83.56% of the companies in the same industry.
ALPAT has a Return On Invested Capital of 1.41%. This is in the better half of the industry: ALPAT outperforms 76.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.84% | ||
| ROE | 9.95% | ||
| ROIC | 1.41% |
ROA(3y)1.24%
ROA(5y)-1.48%
ROE(3y)2.01%
ROE(5y)-3.12%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALPAT's Profit Margin of 48.52% is amongst the best of the industry. ALPAT outperforms 95.89% of its industry peers.
The Operating Margin of ALPAT (11.16%) is better than 82.19% of its industry peers.
With an excellent Gross Margin value of 116.00%, ALPAT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ALPAT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 48.52% | ||
| GM | 116% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
2. Health
2.1 Basic Checks
ALPAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALPAT has more shares outstanding
The number of shares outstanding for ALPAT has been increased compared to 5 years ago.
ALPAT has a better debt/assets ratio than last year.
2.2 Solvency
ALPAT has an Altman-Z score of 0.55. This is a bad value and indicates that ALPAT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.55, ALPAT perfoms like the industry average, outperforming 52.05% of the companies in the same industry.
ALPAT has a debt to FCF ratio of 1.64. This is a very positive value and a sign of high solvency as it would only need 1.64 years to pay back of all of its debts.
The Debt to FCF ratio of ALPAT (1.64) is better than 86.30% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that ALPAT is not too dependend on debt financing.
ALPAT has a Debt to Equity ratio (0.15) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.64 | ||
| Altman-Z | 0.55 |
ROIC/WACC0.21
WACC6.83%
2.3 Liquidity
A Current Ratio of 0.58 indicates that ALPAT may have some problems paying its short term obligations.
ALPAT has a Current ratio of 0.58. This is amonst the worse of the industry: ALPAT underperforms 82.19% of its industry peers.
ALPAT has a Quick Ratio of 0.58. This is a bad value and indicates that ALPAT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.31, ALPAT is not doing good in the industry: 87.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.31 |
3. Growth
3.1 Past
ALPAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1097.57%, which is quite impressive.
The Revenue has grown by 14.61% in the past year. This is quite good.
ALPAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.44% yearly.
EPS 1Y (TTM)1097.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.1%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-43.46%
3.2 Future
Based on estimates for the next years, ALPAT will show a very strong growth in Earnings Per Share. The EPS will grow by 68.40% on average per year.
ALPAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.88% yearly.
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.02, the valuation of ALPAT can be described as very reasonable.
Based on the Price/Earnings ratio, ALPAT is valued cheaply inside the industry as 91.78% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.19, ALPAT is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for ALPAT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.02 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALPAT indicates a somewhat cheap valuation: ALPAT is cheaper than 79.45% of the companies listed in the same industry.
ALPAT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALPAT is cheaper than 97.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.52 | ||
| EV/EBITDA | 15.89 |
4.3 Compensation for Growth
ALPAT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ALPAT may justify a higher PE ratio.
ALPAT's earnings are expected to grow with 68.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y68.4%
EPS Next 3YN/A
5. Dividend
5.1 Amount
ALPAT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALPAT (10/30/2025, 7:00:00 PM)
8.42
-0.02 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners33.62%
Ins Owner ChangeN/A
Market Cap9.43M
Revenue(TTM)1.93M
Net Income(TTM)935.10K
Analysts84.44
Price Target11.73 (39.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.02 | ||
| Fwd PE | N/A | ||
| P/S | 4.89 | ||
| P/FCF | 4.52 | ||
| P/OCF | 3.78 | ||
| P/B | 1 | ||
| P/tB | 1.64 | ||
| EV/EBITDA | 15.89 |
EPS(TTM)0.84
EY9.98%
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)1.86
FCFY22.11%
OCF(TTM)2.23
OCFY26.48%
SpS1.72
BVpS8.39
TBVpS5.14
PEG (NY)0.1
PEG (5Y)N/A
Graham Number12.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.84% | ||
| ROE | 9.95% | ||
| ROCE | 1.96% | ||
| ROIC | 1.41% | ||
| ROICexc | 1.41% | ||
| ROICexgc | 2.1% | ||
| OM | 11.16% | ||
| PM (TTM) | 48.52% | ||
| GM | 116% | ||
| FCFM | 108.17% |
ROA(3y)1.24%
ROA(5y)-1.48%
ROE(3y)2.01%
ROE(5y)-3.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.17%
GM growth 5Y-4.76%
F-Score6
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.64 | ||
| Debt/EBITDA | 1.83 | ||
| Cap/Depr | 73% | ||
| Cap/Sales | 21.4% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 320.17% | ||
| Profit Quality | 222.93% | ||
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.31 | ||
| Altman-Z | 0.55 |
F-Score6
WACC6.83%
ROIC/WACC0.21
Cap/Depr(3y)108.48%
Cap/Depr(5y)137.54%
Cap/Sales(3y)44.29%
Cap/Sales(5y)66.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1097.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.1%
EPS Next Y97.01%
EPS Next 2Y68.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.61%
Revenue growth 3Y-5.79%
Revenue growth 5Y10.44%
Sales Q2Q%-43.46%
Revenue Next Year13.04%
Revenue Next 2Y31.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y128.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y114.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.11%
OCF growth 3YN/A
OCF growth 5YN/A
PLANT ADVANCED TECHNOLOGIES / ALPAT.PA FAQ
Can you provide the ChartMill fundamental rating for PLANT ADVANCED TECHNOLOGIES?
ChartMill assigns a fundamental rating of 5 / 10 to ALPAT.PA.
Can you provide the valuation status for PLANT ADVANCED TECHNOLOGIES?
ChartMill assigns a valuation rating of 7 / 10 to PLANT ADVANCED TECHNOLOGIES (ALPAT.PA). This can be considered as Undervalued.
Can you provide the profitability details for PLANT ADVANCED TECHNOLOGIES?
PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) has a profitability rating of 6 / 10.
What is the financial health of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) stock?
The financial health rating of PLANT ADVANCED TECHNOLOGIES (ALPAT.PA) is 3 / 10.